Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Zoom
ZM
|
+$96M |
| 2 |
Match Group
MTCH
|
+$81.3M |
| 3 |
Peloton Interactive
PTON
|
+$75.6M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$55.6M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$50.7M |
Top Sells
| 1 |
Apple
AAPL
|
+$201M |
| 2 |
Microsoft
MSFT
|
+$112M |
| 3 |
IAC Inc
IAC
|
+$77.1M |
| 4 |
Amazon
AMZN
|
+$73.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$52.8M |
Sector Composition
| 1 | Technology | 26.26% |
| 2 | Healthcare | 14.68% |
| 3 | Consumer Discretionary | 13.69% |
| 4 | Communication Services | 10.36% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
XENT
2051
DELISTED
Intersect ENT, Inc
XENT
| $1.08M | ﹤0.01% |
66,400
+3,100
| +5% | +$50.6K |
|
|
TVTY
2052
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $1.08M | ﹤0.01% |
76,875
+1,200
| +2% | +$16.8K |
|
2053
Preferred Bank
PFBC
$1.17B
| $1.07M | ﹤0.01% |
33,389
| – | – |
|
2054
Option Care Health
OPCH
$4.66B
| $1.07M | ﹤0.01% |
80,100
+1,300
| +2% | +$17.4K |
|
2055
Washington Trust Bancorp
WASH
$570M
| $1.07M | ﹤0.01% |
34,900
| – | – |
|
2056
Guess, Inc.
GES
$868M
| $1.07M | ﹤0.01% |
92,000
+4,100
| +5% | +$47.6K |
|
2057
Transocean
RIG
$3.06B
| $1.07M | ﹤0.01% |
1,323,230
+24,200
| +2% | +$19.5K |
|
2058
Stoneridge
SRI
$229M
| $1.07M | ﹤0.01% |
58,100
| – | – |
|
2059
Omega Flex
OFLX
$341M
| $1.07M | ﹤0.01% |
6,800
| – | – |
|
|
RC
2060
Ready Capital
RC
$675M
| $1.07M | ﹤0.01% |
95,145
+4,400
| +5% | +$49.3K |
|
|
KDMN
2061
DELISTED
Kadmon Holdings, Inc.
KDMN
| $1.07M | ﹤0.01% |
272,000
+4,400
| +2% | +$17.2K |
|
2062
Akero Therapeutics
AKRO
$3.46B
| $1.07M | ﹤0.01% |
34,600
+12,200
| +54% | +$376K |
|
2063
Center Bancorp
CNOB
$1.25B
| $1.07M | ﹤0.01% |
75,700
| – | – |
|
|
USCR
2064
DELISTED
U S Concrete, Inc.
USCR
| $1.05M | ﹤0.01% |
36,200
| – | – |
|
2065
Arvinas
ARVN
$575M
| $1.05M | ﹤0.01% |
44,400
+900
| +2% | +$21.2K |
|
|
PAE
2066
DELISTED
PAE Incorporated Class A Common Stock
PAE
| $1.05M | ﹤0.01% |
123,300
| – | – |
|
2067
Viper Energy
VNOM
$6.62B
| $1.04M | ﹤0.01% |
138,400
+2,200
| +2% | +$16.5K |
|
2068
Alector
ALEC
$287M
| $1.04M | ﹤0.01% |
98,500
+1,500
| +2% | +$15.8K |
|
2069
Relmada Therapeutics
RLMD
$53.4M
| $1.04M | ﹤0.01% |
27,600
+1,000
| +4% | +$37.6K |
|
|
AERI
2070
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $1.04M | ﹤0.01% |
88,100
| – | – |
|
2071
AngioDynamics
ANGO
$445M
| $1.04M | ﹤0.01% |
85,900
| – | – |
|
|
BBT
2072
Beacon Financial Corporation
BBT
$2.2B
| $1.04M | ﹤0.01% |
102,400
+2,800
| +3% | +$28.3K |
|
2073
CEL-SCI Corp
CVM
$66.6M
| $1.03M | ﹤0.01% |
2,700
+53
| +2% | +$20.3K |
|
2074
Ennis
EBF
$463M
| $1.03M | ﹤0.01% |
59,200
+1,000
| +2% | +$17.4K |
|
2075
Community Trust Bancorp
CTBI
$1.04B
| $1.03M | ﹤0.01% |
36,290
+600
| +2% | +$17K |
|